KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Liabilities (2016 - 2026)

AbbVie has reported Other Non-Current Liabilities over the past 14 years, most recently at $32.6 billion for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 8.1% to $32.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.6 billion through Dec 2025, up 8.1% year-over-year, with the annual reading at $32.6 billion for FY2025, 8.1% up from the prior year.
  • Other Non-Current Liabilities was $32.6 billion for Q4 2025 at AbbVie, up from $31.7 billion in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $32.6 billion in Q4 2025 and troughed at $12.5 billion in Q1 2021.
  • The 5-year median for Other Non-Current Liabilities is $18.9 billion (2023), against an average of $20.7 billion.
  • Year-over-year, Other Non-Current Liabilities soared 82.5% in 2021 and then decreased 2.43% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $14.9 billion in 2021, then grew by 10.06% to $16.4 billion in 2022, then rose by 21.4% to $19.9 billion in 2023, then skyrocketed by 51.48% to $30.1 billion in 2024, then rose by 8.1% to $32.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Non-Current Liabilities are $32.6 billion (Q4 2025), $31.7 billion (Q3 2025), and $32.0 billion (Q2 2025).